Teva Board Members Take 50% Pay Cut Post author:Sam Post published:January 10, 2018 Post category:BioPharma Teva has made a target of cutting costs by $3B by the end of 2019. Source: BioSpace You Might Also Like ThromboGenics Struggles to Find Patients for Phase II Eye Disease Trial December 7, 2017 Why Struggling MannKind is Struggling No More September 19, 2017 Aurora Diagnostics Inc. Acquires April 11, 2016
